Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1381908
                    [Title] => ‘Chemobrain’ may start before chemotherapy
                    [Summary] => 
The muddled thinking that sometimes affects breast cancer patients is manifested by decreased activity in a brain region that plays a key role in working memory, according to results of a functional imaging study.

                    [DatePublished] => 2014-10-19 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 1252258
                    [Title] => FDA approves Roche drug for chronic leukemia based on research that it slows disease
                    [Summary] => 
The Food and Drug Administration on Friday approved a new drug from Roche to help treat patients with a type of cancer of the blood and bone marrow.

                    [DatePublished] => 2013-11-02 05:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img534.imageshack.us/img534/3584/4nve.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 911748
                    [Title] => Hair, care, share: Hair loss adds to cancer trauma
                    [Summary] => 
The gravity of her son’s illness struck Maria Roleta Miranda hard when she saw strands of hair on the boy’s pillow one morning last week.

                    [DatePublished] => 2013-02-22 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => News Commentary
                    [SectionUrl] => news-commentary
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 768485
                    [Title] => My head is now covered with hair
                    [Summary] => 
After months of chemotherapy and weeks of radiation, I am happy to share that the most critical and challenging part of my treatment is over.
                    [DatePublished] => 2012-01-18 00:00:00
                    [ColumnID] => 134670
                    [Focus] => 0
                    [AuthorID] => 1767481
                    [AuthorName] => Tetta Matera
                    [SectionName] => Fashion and Beauty
                    [SectionUrl] => fashion-and-beauty
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 743585
                    [Title] => Roche launches  drug for advanced  ovarian cancer
                    [Summary] => 
Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
                    [DatePublished] => 2011-11-03 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 742896
                    [Title] => First-line treatment for advanced ovarian cancer
                    [Summary] => 
Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
                    [DatePublished] => 2011-11-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 740509
                    [Title] => Breast cancer:  Progress & promise in 2011
                    [Summary] => 
The field of breast cancer has been a model for innovation and discovery.
                    [DatePublished] => 2011-10-25 00:00:00
                    [ColumnID] => 133436
                    [Focus] => 0
                    [AuthorID] => 1778504
                    [AuthorName] => Tyrone M. Reyes M.D.
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img714.imageshack.us/img714/6105/lif1thumba.jpg
                )

            [7] => Array
                (
                    [ArticleID] => 712918
                    [Title] => Chavez prepares for second round of chemotherapy
                    [Summary] => 
 Venezuelan President Hugo Chavez said Wednesday that he had well prepared himself both physically and spiritually for a second phase of chemotherapy to treat his cancer that would begin in the upcoming hours.
                    [DatePublished] => 2011-08-04 11:05:56
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 696213
                    [Title] => Roche drug halves risk of disease worsening in women with recurrent ovarian cancer
                    [Summary] => 
Roche recently announced the results from OCEANS, a phase III study evaluating bevacizumab in combination with chemotherapy (gemcitabine and carboplatin) followed by the continued use of bevacizumab alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
                    [DatePublished] => 2011-06-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 678152
                    [Title] => Roche bares positive results of breast cancer drug
                    [Summary] => 
BASEL, Switzerland — Roche has announced the topline results of its first randomized trial of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer.
                    [DatePublished] => 2011-04-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

CHEMOTHERAPY

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1381908
                    [Title] => ‘Chemobrain’ may start before chemotherapy
                    [Summary] => 
The muddled thinking that sometimes affects breast cancer patients is manifested by decreased activity in a brain region that plays a key role in working memory, according to results of a functional imaging study.

                    [DatePublished] => 2014-10-19 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 1252258
                    [Title] => FDA approves Roche drug for chronic leukemia based on research that it slows disease
                    [Summary] => 
The Food and Drug Administration on Friday approved a new drug from Roche to help treat patients with a type of cancer of the blood and bone marrow.

                    [DatePublished] => 2013-11-02 05:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img534.imageshack.us/img534/3584/4nve.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 911748
                    [Title] => Hair, care, share: Hair loss adds to cancer trauma
                    [Summary] => 
The gravity of her son’s illness struck Maria Roleta Miranda hard when she saw strands of hair on the boy’s pillow one morning last week.

                    [DatePublished] => 2013-02-22 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => News Commentary
                    [SectionUrl] => news-commentary
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 768485
                    [Title] => My head is now covered with hair
                    [Summary] => 
After months of chemotherapy and weeks of radiation, I am happy to share that the most critical and challenging part of my treatment is over.
                    [DatePublished] => 2012-01-18 00:00:00
                    [ColumnID] => 134670
                    [Focus] => 0
                    [AuthorID] => 1767481
                    [AuthorName] => Tetta Matera
                    [SectionName] => Fashion and Beauty
                    [SectionUrl] => fashion-and-beauty
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 743585
                    [Title] => Roche launches  drug for advanced  ovarian cancer
                    [Summary] => 
Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
                    [DatePublished] => 2011-11-03 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 742896
                    [Title] => First-line treatment for advanced ovarian cancer
                    [Summary] => 
Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
                    [DatePublished] => 2011-11-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 740509
                    [Title] => Breast cancer:  Progress & promise in 2011
                    [Summary] => 
The field of breast cancer has been a model for innovation and discovery.
                    [DatePublished] => 2011-10-25 00:00:00
                    [ColumnID] => 133436
                    [Focus] => 0
                    [AuthorID] => 1778504
                    [AuthorName] => Tyrone M. Reyes M.D.
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img714.imageshack.us/img714/6105/lif1thumba.jpg
                )

            [7] => Array
                (
                    [ArticleID] => 712918
                    [Title] => Chavez prepares for second round of chemotherapy
                    [Summary] => 
 Venezuelan President Hugo Chavez said Wednesday that he had well prepared himself both physically and spiritually for a second phase of chemotherapy to treat his cancer that would begin in the upcoming hours.
                    [DatePublished] => 2011-08-04 11:05:56
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 696213
                    [Title] => Roche drug halves risk of disease worsening in women with recurrent ovarian cancer
                    [Summary] => 
Roche recently announced the results from OCEANS, a phase III study evaluating bevacizumab in combination with chemotherapy (gemcitabine and carboplatin) followed by the continued use of bevacizumab alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
                    [DatePublished] => 2011-06-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 678152
                    [Title] => Roche bares positive results of breast cancer drug
                    [Summary] => 
BASEL, Switzerland — Roche has announced the topline results of its first randomized trial of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer.
                    [DatePublished] => 2011-04-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest